Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-11, Stock:JNJ, The news for the past five days is as follows:
2019-06-04: NEWS1: St. Louis-based firm wins $325M in Johnson & Johnson talc trial.NEWS2: Obalon Clinches First US Patent For Obesity Treatment Placement System.NEWS3: Mini-tender spree of lowball stock offers lands on Lockheed.NEWS4: Pharma groups combine to promote drug discovery with AI.NEWS5: Dow Jones Today: 4 Big Stocks That Could Be in Big Trouble.NEWS6: Dow Jones Today: 4 Big Stocks That Could Be in Big Trouble.
2019-06-05: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Christopher Browne: Finding the Silver Lining When Markets Dip.NEWS3: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS4: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS5: 10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors.NEWS6: 10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors.NEWS7: Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Behind (and above) the scenes at BIO 2019 exhibit hall (Photos).NEWS10: Check out the exhibit hall action at BIO 2019 (Photos).NEWS11: Johnson & Johnson Releases 2018 Health for Humanity Report.NEWS12: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.
2019-06-06: NEWS1: Celgene & Acceleron's BLA for Luspatercept Accepted by FDA.NEWS2: Celgene & Acceleron's BLA for Luspatercept Accepted by FDA.NEWS3: Are Hedge Funds Going To Get Burned By Johnson & Johnson (JNJ) ?.NEWS4: JNJ Crosses Above Key Moving Average Level.NEWS5: JNJ Crosses Above Key Moving Average Level.NEWS6: Celgene & Acceleron's BLA for Luspatercept Accepted by FDA.NEWS7: Top Stock Reports for Johnson & Johnson, Chevron & Adobe.NEWS8: Top Stock Reports for Johnson & Johnson, Chevron & Adobe.NEWS9: Top Stock Reports for Johnson & Johnson, Chevron & Adobe.NEWS10: Health Care Sector Update for 06/06/2019: MTFB, PLX, SEEL, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 06/06/2019: MTFB, PLX, SEEL, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Opioid maker Insys agrees to pay $225m to settle US criminal cases.NEWS13: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS14: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.
2019-06-07: NEWS1: Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson.NEWS2: Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache.NEWS3: Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Chevron, Adobe, Las Vegas Sands and Southern Copper.NEWS5: The Zacks Analyst Blog Highlights: Johnson & Johnson, Chevron, Adobe, Las Vegas Sands and Southern Copper.NEWS6: QUAL, IG: Big ETF Outflows.NEWS7: QUAL, IG: Big ETF Outflows.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, Chevron, Adobe, Las Vegas Sands and Southern Copper.NEWS9: Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache.NEWS10: Health Care Sector Update for 06/07/2019: LJPC, TXMD, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 06/07/2019: LJPC, TXMD, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Teva and J&J Stocks Were Hit by Opioid Worries. What Could Come Next..NEWS13: JNJ a Top 25 Dividend Giant With $38.54B Held By ETFs.NEWS14: JNJ a Top 25 Dividend Giant With $38.54B Held By ETFs.NEWS15: Should You Be Holding Johnson & Johnson (NYSE:JNJ)?.NEWS16: How Funds That Chase the Hottest Stocks Can Still Lag Behind.NEWS17: UPDATE 3-Drugmaker Sanofi hires Hudson from Novartis as CEO.NEWS18: CORRECTED-UPDATE 2-Drugmaker Sanofi appoints Novartis' Hudson as CEO.
2019-06-10: NEWS1: How Analysts Rate Tandem Diabetes Care and Insulet.NEWS2: These 3 Biotech Stocks Doubled in the First Half of 2019.NEWS3: These 3 Biotech Stocks Doubled in the First Half of 2019.NEWS4: Health Care Sector Update for 06/10/2019: INSY, TLRY, ONCE, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Health Care Sector Update for 06/10/2019: INSY, TLRY, ONCE, JNJ, PFE, ABT, MRK, AMGN.NEWS6: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS7: Here&apos;s Why Arrowhead Pharmaceuticals Surged 31.9% in May.

Answer: Rise